Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase for Acute Wake-up and Unclear-onset Strokes (THAWS)
NCT02002325Phase 3Unknown
- Sponsor
- National Cerebral and Cardiovascular Center
- Start
- May 2014
- Primary completion
- Dec 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by National Cerebral and Cardiovascular Center. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02002325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002325.